Ambiq Micro, Inc. announces a public offering of 2.2 million shares of common stock, subject to market conditions.
Quiver AI Summary
Ambiq Micro, Inc. has announced an underwritten public offering of 2,200,000 shares of its common stock, with 2,157,051 shares coming from the company and 42,949 shares from certain stockholders. Additionally, the underwriters may purchase up to another 330,000 shares within 30 days. The offering is subject to market conditions, and completion is uncertain. BofA Securities and UBS Investment Bank are leading the offering, with a registration statement filed with the SEC that has not yet become effective, meaning the securities cannot yet be sold. Ambiq, based in Austin, Texas, specializes in ultra-low-power semiconductor solutions for edge AI, having powered over 290 million devices to date. The release contains forward-looking statements regarding the offering and Ambiq's plans, which are inherently uncertain.
Potential Positives
- Ambiq Micro is initiating a public offering of 2,200,000 shares of common stock, indicating confidence in its market position and the potential for raising capital for growth initiatives.
- The company expects to grant underwriters an option to purchase an additional 330,000 shares, which may enhance liquidity and investor interest in the offering.
- Ambiq's technology, which focuses on ultra-low-power semiconductor solutions, demonstrates its innovative capabilities and may attract further investment within the edge AI market.
- Ambiq has already powered over 290 million devices, showcasing its established presence and success in the semiconductor industry.
Potential Negatives
- Commencement of a public offering could indicate underlying financial pressure or the need for capital, which may raise concerns among investors about the company's financial health.
- The offering is subject to market conditions, leading to uncertainty about its success and potential dilution of existing shareholders’ equity.
- The requirement for a registration statement to become effective before any securities can be sold may delay access to capital, impacting operational flexibility.
FAQ
What is Ambiq Micro's latest public offering?
Ambiq Micro has announced a public offering of 2,200,000 shares of common stock, including shares from stockholders.
Who are the underwriters for the offering?
BofA Securities and UBS Investment Bank are the joint lead book-running managers for the proposed offering.
What is the purpose of the offering?
The offering aims to raise capital for Ambiq Micro's ultra-low-power semiconductor solutions and artificial intelligence initiatives.
How can I obtain the preliminary prospectus?
Copies of the preliminary prospectus can be requested from BofA Securities or UBS Securities using provided contact details.
Are there any risks associated with the offering?
Yes, the offering is subject to market conditions and various risks, as detailed in Ambiq's filings with the SEC.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$AMBQ Hedge Fund Activity
We have seen 71 institutional investors add shares of $AMBQ stock to their portfolio, and 1 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ATREIDES MANAGEMENT, LP added 684,307 shares (+inf%) to their portfolio in Q3 2025, for an estimated $20,474,465
- ALLIANCEBERNSTEIN L.P. added 436,154 shares (+inf%) to their portfolio in Q3 2025, for an estimated $13,049,727
- KADENSA CAPITAL LTD added 394,991 shares (+inf%) to their portfolio in Q3 2025, for an estimated $11,818,130
- VANGUARD GROUP INC added 307,836 shares (+inf%) to their portfolio in Q3 2025, for an estimated $9,210,453
- BLACKROCK, INC. added 291,876 shares (+inf%) to their portfolio in Q3 2025, for an estimated $8,732,929
- SCHONFELD STRATEGIC ADVISORS LLC added 274,087 shares (+inf%) to their portfolio in Q3 2025, for an estimated $8,200,683
- MONASHEE INVESTMENT MANAGEMENT LLC added 200,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $5,984,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$AMBQ Analyst Ratings
Wall Street analysts have issued reports on $AMBQ in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 08/25/2025
- Stifel issued a "Buy" rating on 08/25/2025
To track analyst ratings and price targets for $AMBQ, check out Quiver Quantitative's $AMBQ forecast page.
$AMBQ Price Targets
Multiple analysts have issued price targets for $AMBQ recently. We have seen 4 analysts offer price targets for $AMBQ in the last 6 months, with a median target of $43.5.
Here are some recent targets:
- Timothy Arcuri from UBS set a target price of $32.0 on 10/27/2025
- N. Quinn Bolton from Needham set a target price of $48.0 on 08/25/2025
- Vivek Arya from B of A Securities set a target price of $42.0 on 08/25/2025
- Tore Svanberg from Stifel set a target price of $45.0 on 08/25/2025
Full Release
AUSTIN, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Ambiq Micro, Inc. (“Ambiq”) (NYSE: AMBQ), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced the commencement of an underwritten public offering of 2,200,000 shares of its common stock, which includes 2,157,051 shares of common stock offered by Ambiq and 42,949 shares of common stock offered by certain of Ambiq’s stockholders. In addition, Ambiq expects to grant the underwriters an option for a period of 30 days to purchase up to an additional 330,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
BofA Securities and UBS Investment Bank are acting as joint lead book-running managers for the proposed offering. Needham & Company and Stifel are acting as joint book-running managers for the proposed offering.
A registration statement on Form S-1, including a prospectus, relating to the proposed offering of securities has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. Accordingly, these securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. The proposed offering will be made only by means of a prospectus. Copies of the preliminary prospectus relating to the proposed offering may be obtained by contacting: BofA Securities, NC1-022-02-25, 201 North Tryon Street, Charlotte, North Carolina 28255-0001, Attention: Prospectus Department, or by email at [email protected] or UBS Securities LLC, Attention: Prospectus Department, 11 Madison Avenue, New York, New York 10010, by telephone at (833) 481-0260.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
About Ambiq
Headquartered in Austin, Texas, Ambiq’s mission is to enable intelligence (artificial intelligence (AI) and beyond) everywhere by delivering the lowest power semiconductor solutions. Ambiq enables its customers to deliver AI compute at the edge where power consumption challenges are the most severe. Ambiq’s technology innovations, built on the patented and proprietary subthreshold power optimized technology (SPOT®), fundamentally deliver a multi-fold improvement in power consumption over traditional semiconductor designs. Ambiq has powered over 290 million devices to date.
Forward-Looking Statements
The statements contained in this press release that are not historical facts are forward-looking statements. You can identify forward-looking statements because they contain words such as “believes,” “expects,” “may,” “will,” “should,” “seeks,” “intends,” “plans,” “estimates,” or “anticipates,” or similar expressions which concern our strategy, plans, projections or intentions. These forward-looking statements may be included throughout this press release, and include, but are not limited to, statements relating to the timing and size of the offering, the expected closing of the offering and the grant to the underwriters of the option to purchase additional shares. By their nature, forward-looking statements are not statements of historical fact or guarantees of future performance and are subject to risks, uncertainties, assumptions or changes in circumstances that are difficult to predict or quantify including those described in the section titled “Risk Factors” in Ambiq’s Quarterly Report on 10-Q for the quarter ended September 30, 2025, as well as in other filings Ambiq may make with the SEC in the future. Ambiq’s expectations, beliefs and projections are expressed in good faith and Ambiq believes there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs and projections will result or be achieved and actual results may vary materially from what is expressed in or indicated by the forward-looking statements. Any forward-looking statement in this press release speaks only as of the date of this release. Ambiq undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws.
Company Contact:
Charlene Wan
VP of Corporate Marketing
[email protected]
Investor Relations Contacts:
Teneo
Christina Coronios
[email protected]
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/42ad9459-6d3f-40de-8c38-119c12e1d316